Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
Clinical trial NCT03324425 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03324425
- Sponsor
- Baylor Breast Care Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-04
- Primary completion
- 2028-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.